Loading clinical trials...
Loading clinical trials...
The purpose of this study was to look at the safety and effectiveness of a once-daily dose of tigecycline compared to ertapenem for the treatment of diabetic foot infections. The co-primary efficacy e...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT07161830 · Diabetic Foot Ulcer
NCT06383013 · Diabetic Foot Ulcer
NCT07541196 · Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU), and more
NCT07260656 · Diabetic Neuropathies, Painful, Diabetic Foot, and more
NCT05645107 · Hypogammaglobulinemia, Bacterial Infections, and more
Los Angeles, California
Los Angeles, California
Northridge, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions